“The best conference this year. Sharing a picture of the implementation of CT in all these regions”
Project Manager, Boehringer Ingelheim
“Global Engage are well organised, professional and very attentive to needs.
I enjoyed the quality of delegates that are attracted to this event.”
Director, International Sales, CoreLab Partners
The ongoing globalisation of clinical trials is having an ever increasing impact on the biopharmaceutical industry. Driven by the need to reduce development costs and the need to access larger numbers of patients so called emerging regions such as Latin America, Central and Eastern Europe, Russia, Middle East, India and Asia Pacific are now playing an important role.
The 3rd Cardiovascular Clinical Trials in Emerging Countries will examine issues such as regulatory and organisational challenges, appropriate trial design, data collection, patient enrolment and multi national cost saving strategies.
This conference will be co-located with the 4th Oncology Clinical Trials in Emerging Regions. 92 senior level delegates attended this event last year when it was also co-located with the 2nd Oncology Clinical Trials in emerging Countries. Some of the vendor companies who attended were Arianne Corporation, DHL Supply Chain, Averion International, ClinStar, Quest Diagnostics, ClinTec International, CoreLab Partners, ERT, Quintiles, Interlab, Latin America Trial Network, Medidata Solutions, Orion Clinical Research, Synergy Research, Synevo Central Lab, Worldwide Clinical Trials.
Click here for more information on Cardiovascular Clinical Trials in Emerging Countries.
Whilst the US and Europe still dominate the contract research outsourcing market and account for the majority of clinical research activities there is an ongoing and growing change with the emergence of regions such as Central and Eastern Europe, Latin America, Asia Pacific India, China as well as the Middle East becoming increasingly important as a preferred location for outsourcing.
This conference will focus on the challenges and benefits of conducting Oncology clinical trials in emerging regions and draw cost/benefit comparisons with that of more established countries.
This conference will be co-located with the 3rd Cardiovascular Clinical Trials in Emerging Countries – see above for attending delegates and vendor companies.
Click here for more information on Oncology Clinical Trials in Emerging Regions.
Asia’s prominence as an outsourcing destination for clinical trials continues to grow and in particular due to streamlined approval times and regulatory procedures clinical trials taking place in Korea have more than doubled in the last five years.
The Global Clinical Trials Outsourcing Summit will examine operational, regulatory and logistical considerations when outsourcing to Korea and other countries in the Asia Pacific region.
Click here for more information on the Global Clinical Trials Outsourcing Summit.
Traditionally the local pharmaceutical industry in Asia has been dominated by generic pharmaceutical companies. Multi-National companies setting up operations or outsourcing to countries in the Asia Pacific region have therefore had strong concerns about Intellectual Property (IP) in these countries.
Pharmaceutical IP Protection in Asia (PIPPA) will address the ongoing legislative changes to IP protection in countries such as India, China, Singapore and Korea providing a platform for pharmaceutical legal counsel and the legal profession to exchange views and assess current trends.
Click here for more information on Pharmaceutical IP Protection in Asia.
Whilst the West continues to invest ever increasing amounts of time and money into outsourcing research and development into China, pharmaceutical companies in China are now seeking to commercialise their products in Western markets. As from March 1st 2011 the SFDA in China introduced revised regulations for Good Manufacturing Practice (GMP). All existing Chinese Pharmaceutical manufacturing facilities will have to adhere to the new regulations by the end of 2013 and new facilities by 2015 in order to continue operating and distributing in China.
This conference will attract over 150 CEOs and VPs from Chinese Pharmaceutical companies and provide an in depth look at new SFDA GMP regulations and how this will effect the commercialisation of generic drugs into Europe and the USA.
Click here for more information on the China GMP Conference
Now firmly established as the largest conference outside of the mainland focused on China as destination for outsourcing clinical trials, this years event will review the ever changing regulatory climate in China as well as addressing strategic and operational challenges . Issues such as the increase in Western diseases such diabetes and cardiovascular issues and the potential and challenges that this holds for conducting clinical trials in these areas will also be examined.
Average attendance of over 100 senior-level Pharma/Biotech delegates. Some of the vendor companies who have attended on a repeat basis are Research Pharmaceutical Services (RPS), Quest Diagnostics, DHL Supply Chain, ICON, World Courier, George Clinical, Korea Clinical Development Institute, PRA International, Covance, Parexel, PharmaNet, INTERLAB, CoreLab and Quintiles.
This conference will be co-located with the 2nd Asia Clinical Trials Outsourcing Congress
Click here for more information on the China Clinical Trials Outsourcing Congress.
Whilst China and India continue to be the main outsourcing destination for conducting clinical trials other countries such Singapore, Malaysia, Taiwan, South Korea are playing an increasingly important role. The 2nd Asia Clinical Trials Outsourcing Congress will examine operational and regulatory challenges of conducting clinical trials in these countries through a series of presentations, case studies and panel discussions given by regional experts.
This conference will be co-located with the 4th China Clinical Trials Outsourcing Congress – attending delegates and vendor companies as above.
Click here for more information on the Asia Clinical Trials Outsourcing Congress.
Oncology continues to be the fastest growing sector in the pharmaceutical industry. This year’s conference will focus on the vital factors involved in the execution of multi national Oncology clinical trials in emerging regions and explore associated intellectual property, regulatory, operational and strategic issues. The role that emerging regions such as Latin America, Central and Eastern Europe, Russia, Middle East and Asia Pacific now play in conducting oncology clinical trials will be examined along with regional considerations and benefits when selecting a region.
Average attendance of over 80 senior-level Pharma/Biotech delegates. Some of the vendor companies who have attended include ClinStar, Nuvisan, INC Research, Dokumeds, Quest Diagnostics, SIRO ClinPharm, BARC Central Labs, CMED, and DiagnoSearch Life Sciences.
Click here for more information see the earlier European Conference.
As drug development costs continue to rise and become evermore competitive many small and large bio-pharmaceutical companies are turning towards the Asia Pacific region to gain greater value from their R&D operations. This has resulted in ever increasing investment into the region.
The Asia Pharma R&D Outsourcing Congress will examine the current role of the Asia Pacific region as a potential partner for outsourcing drug discovery programs, addressing the benefits and challenges through a series of interactive presentations and panel discussions.
This event was held last year for the first time and 72 delegates attended from all over the world and provided a platform the event to grow still further in 2012. Vendor/Supplier companies who attended were Absorption Systems, Aurigene Discovery, BioDuro, ChemPartner China, Fountain Medical Development China, GenScript, VLife Sciences.
Click here for more information on the Asia R&D Outsourcing Congress.
**************************
Global Engage’s Conferences and Congresses provide a unique variety of attendance options incorporating sponsorship opportunities , half or one-day workshops, speaking positions on the main conference programme, private one-to-one delegate meetings, pre and post-event marketing and exhibition booths situated in the main networking and meeting area. We are pleased to provide discounted proposals for companies expressing interest in attending multiple conferences throughout the year which can include tailored packages and payment terms.